Wesper is making significant strides in the field of sleep apnea management by combining advanced home sleep testing technology with insights into metabolic health. The company’s innovative approach is particularly relevant following the FDA’s approval of GLP-1 receptor agonists for treating sleep apnea.

A recent study conducted by Wesper highlights the interplay between obesity, age, and gender in influencing sleep apnea severity. Key metrics such as the Apnea-Hypopnea Index (AHI) and Hypoxic Burden (HB) were analyzed, with the latter emerging as a crucial indicator of cardiovascular risks associated with sleep apnea. The study, which included over 1,300 patients, revealed that weight gain and aging significantly exacerbate sleep apnea, with men facing higher risks compared to women.

In response to these findings and in the hopes of improving sleep apnea management, Wesper launched a highly accurate home sleep apnea test. The system also tracks advanced metrics like Hypoxic Burden and provides healthcare providers with detailed data to tailor treatments effectively. Its user-friendly design and ability to record multi-night data further enhance its appeal.

Image Credit: Wesper